Exploration of Medicine

Declarations

Author contributions

KS: Conceptualization, Methodology, Writing—original draft, Writing—review & editing.

Conflicts of interest

The author declares that she has no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, et al. The antitumor activities of flavonoids. In Vivo. 2005;19:895–909. Erratum in: In Vivo. 2007;21:553. Erratum in: In Vivo. 2007;21:1172. [PubMed]

Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases. Cells. 2020;9:1076. [DOI] [PubMed] [PMC]

Singh D, Srivastava SK, Chaudhuri TK, Upadhyay G. Multifaceted role of matrix metalloproteinases (MMPs). Front Mol Biosci. 2015;2:19. [DOI] [PubMed] [PMC]

Zitka O, Kukacka J, Krizkova S, Huska D, Adam V, Masarik M, et al. Matrix metalloproteinases. Curr Med Chem. 2010;17:3751–68. [DOI] [PubMed]

Ågren MS, Auf dem Keller U. Matrix metalloproteinases: how much can they do? Int J Mol Sci. 2020;21:2678. [DOI] [PubMed] [PMC]

Galliera E, Tacchini L, Corsi Romanelli MM. Matrix metalloproteinases as biomarkers of disease: updates and new insights. Clin Chem Lab Med. 2015;53:349–55. [DOI] [PubMed]

Wang LS, Stoner GD. Anthocyanins and their role in cancer prevention. Cancer Lett. 2008;269:281–90. [DOI] [PubMed] [PMC]

Zeka K, Ruparelia K, Arroo RRJ, Budriesi R, Micucci M. Flavonoids and their metabolites: prevention in cardiovascular diseases and diabetes. Diseases. 2017;5:19. [DOI] [PubMed] [PMC]

Grijalva-Guiza RE, Jiménez-Garduño AM, Hernández LR. Potential benefits of flavonoids on the progression of atherosclerosis by their effect on vascular smooth muscle excitability. Molecules. 2021;26:3557. [DOI] [PubMed] [PMC]

10.

Salvamani S, Gunasekaran B, Shaharuddin NA, Ahmad SA, Shukor MY. Antiartherosclerotic effects of plant flavonoids. Biomed Res Int. 2014;2014:480258. [DOI] [PMC]

11.

Sánchez M, Romero M, Gómez-Guzmán M, Tamargo J, Pérez-Vizcaino F, Duarte J. Cardiovascular effects of flavonoids. Curr Med Chem. 2019;26:6991–7034. [DOI] [PubMed]

12.

Li RL, Wang LY, Liu S, Duan HX, Zhang Q, Zhang T, et al. Natural flavonoids derived from fruits are potential agents against atherosclerosis. Front Nutr. 2022;9:862277. [DOI] [PubMed] [PMC]

13.

Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr. 2004;24:511–38. [DOI] [PubMed]

14.

Zhang S, Li L, Chen W, Xu S, Feng X, Zhang L. Natural products: the role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytother Res. 2021;35:2945–67. [DOI] [PubMed]

15.

Schramm DD, German JB. Potential effects of flavonoids on the etiology of vascular disease. J Nutr Biochem. 1998;9:560–6. [DOI]

16.

García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 2009;58:537–52. [DOI] [PubMed]

17.

Cano A, García-Pérez MA, Tarín JJ. Isoflavones and cardiovascular disease. Maturitas. 2010;67:219–26. [DOI] [PubMed]

18.

Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med. 2010;31:478–94. [DOI] [PubMed]

19.

Zhang ZK, Li J, Yan DX, Leung WN, Zhang BT. Icaritin inhibits collagen degradation-related factors and facilitates collagen accumulation in atherosclerotic lesions: a potential action for plaque stabilization. Int J Mol Sci. 2016;17:169. [DOI] [PubMed] [PMC]

20.

Wang QM, Wang H, Li YF, Xie ZY, Ma Y, Yan JJ, et al. Inhibition of EMMPRIN and MMP-9 expression by epigallocatechin-3-gallate through 67-kDa laminin receptor in PMA-induced macrophages. Cell Physiol Biochem. 2016;39:2308–19. [DOI] [PubMed]

21.

Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, et al. Flavonoids in cancer metastasis. Cancers. 2020;12:1498. [DOI] [PubMed] [PMC]

22.

Clere N, Faure S, Martinez MC, Andriantsitohaina R. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem. 2011;9:62–77. [DOI] [PubMed]

23.

Forni C, Rossi M, Borromeo I, Feriotto G, Platamone G, Tabolacci C, et al. Flavonoids: a myth or a reality for cancer therapy? Molecules. 2021;26:3583. [DOI] [PubMed] [PMC]

24.

Liskova A, Koklesova L, Samec M, Varghese E, Abotaleb M, Samuel SM, et al. Implications of flavonoids as potential modulators of cancer neovascularity. J Cancer Res Clin Oncol. 2020;146:3079–96. [DOI] [PubMed]

25.

Mirossay L, Varinská L, Mojžiš J. Antiangiogenic effect of flavonoids and chalcones: an update. Int J Mol Sci. 2017;19:27. [DOI] [PubMed] [PMC]

26.

Mojzis J, Varinska L, Mojzisova G, Kostova I, Mirossay L. Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res. 2008;57:259–65. [DOI] [PubMed]

27.

Yao H, Xu W, Shi X, Zhang Z. Dietary flavonoids as cancer prevention agents. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011;29:1–31. [DOI] [PubMed]

28.

Raffa D, Maggio B, Raimondi MV, Plescia F, Daidone G. Recent discoveries of anticancer flavonoids. Eur J Med Chem. 2017;142:213–28. [DOI] [PubMed]

29.

Liang D, Liu L, Zhao Y, Luo Z, He Y, Li Y, et al. Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer. Front Pharmacol. 2023;14:1186712. [DOI] [PubMed] [PMC]

30.

Sak K. Plant flavonoids against metastasis: new concepts for cancer treatment. New York: Nova Science Publishers; 2021.